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Abstract
Background: There are still ambiguities existing in regard to left ventricular non-compaction (LVNC) diagnostic
imaging. The aim of our study was to analyze diagnostic potential of late gadolinium enhancement (LGE) and
ventricle geometry in patients with LVNC and controls.
Methods: Data on cardiac magnetic resonance imaging (CMR) studies for LVNC were reassessed from the hospital’s
database (3.75 years; n=1975 exams). Matching sample of controls included cases with no structural heart disease,
hypertrophic or dilative cardiomyopathy, arrhythmogenic right ventricular dysplasia or subacute myocarditis.
Eccentricity of the left ventricle was measured at end diastole in the region with pronounced NC and maximal to
minimal ratio (MaxMinEDDR) was calculated.
Results: Study included 255 patients referred for CMR, 100 (39.2%) with LVNC (prevalence in the studied period 5.01%)
and 155 (60.8%) controls. Existing LGE had sensitivity of 52.5% (95%-CI:42.3–62.5), specificity of 80.4% (95%-CI:73.2–86.5)
for LVNC, area under curve (AUC) 0.664 (95%-CI:0.603–0.722);p<0.001. MaxMinEDDR>1.10 had sensitivity of 95.0% (95%-
CI:88.7–98.4), specificity of 82.6% (95%-CI: 75.7–88.2) for LVNC, AUC 0.917 (95%-CI:0.876–0.948); p<0.001. LGE correlated
with Max-Min-EDD-R (Rho=0.130; p=0.038) and there was significant difference in ROC analysis ΔAUC0.244 (95%-CI:0.
175–0.314); p<0.001. LGE also correlated negatively with stroke volume and systolic function (both p<0.05, respectively).
Conclusions: LGE was found to be frequently expressed in patients with LVNC, but without sufficient power to
be used as a discriminative diagnostic parameter. Both LGE and eccentricity of the left ventricle were found
to be relatively solid diagnostic landmarks of complex infrastructural and functional changes within the failing heart.
Keywords: Left ventricle non-compaction (LVNC), Late gadolinium enhancement (LGE), Cardiac magnetic resonance
imaging (CMR), Left ventricular geometry
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Background
Left ventricle non-compaction (LVNC) is cardiomyop-
athy of infrequent prevalence, but associated with
serious adverse prognostic outcomes [1, 2]. There is a
complex pathophysiologic background made up of
inherited and external factors, whose interplay leads to
alterations in cellular organization or signaling, myocar-
dial wall maturation, loss of systolic function, increased
likelihood of arrhythmias and intracardial thrombosis
[3–5]. On the other side, due to great variability of clin-
ical expression and presentation, currently available
diagnostic criteria are not perfect [6]. Trabeculations of
the left ventricle can indeed be found in non-negligible
number of imaging studies, but their clinical significance
is often inconclusive, particularly in cases in which
prognostic assessment is solely based on imaging. In
some cases genetic testing can offer valuable land-
mark that can reveal a concealed risk of sudden car-
diac death [7, 8].
Specific characteristics of LVNC, such as compact (C)
myocardial wall thinning, pronounced meshwork of
non-compact (NC) myocardium with 2.0–2.3 ratio of
NC/C and a proof of blood flow through the trabecula,
taken cumulatively together make that only some cases
with trabeculated myocardium fit within the LVNC car-
diomyopathy [9–11]. Proportion of non-compact myo-
cardium in the total mass of the left ventricle was also
found to be a highly sensitive and specific diagnostic
parameter in cases in which over one fifth of the ven-
tricle is affected [12]. Remarkable advancements in diag-
nosing LVNC came with wider availability of cardiac
magnetic resonance imaging (CMR) [13, 14]. Thanks to
excellent insight in volumetrics, three dimensional mul-
tiplanarity, geometry and tissue changes, CMR offers
valuable data for verification of the LVNC diagnosis, as
well as functional analysis and insight in the prognostic
course, superior to the conventional imaging modalities
[12, 15]. Tissue characterization, especially the late gado-
linium enhancement (LGE), offer further information on
pathophysiology, differential diagnosis, as well as pathoa-
natomic background for increased prevalence of arrhyth-
mias or thromboses [16, 17].
Previous studies have shown that existence of LGE in
LVNC is associated with deprived prognostic course
[18, 19]. Left ventricle (LV) geometry was only scarcely
studied in regard to LVNC [17]. Our preliminary findings,
based on large volume of exams, found that eccentricity of
the left ventricle is connected with LVNC. The aim of our
study was to assess the existence, characteristics and diag-
nostic potential of LGE in patients with LVNC and con-
trols, using CMR. In addition, connections existing
between LGE and geometry of the left ventricle were sys-
tematically assessed, with particular interest on their head
to head diagnostic utility.
Methods
Patients referred for CMR imaging of non-ischemic car-
diomyopathies were prospectively included in our regis-
try after signing an informed consent, prior to imaging
procedure. Study was conducted in accordance with the
Declaration of Helsinki and good clinical practice princi-
ples. Approval was obtained from the ethical board of
the Hospital. There was no funding, compensations or
other sources of financing, and there was no relation
with medical industry. There were no additional or in-
direct reimbursements for patients or study personnel.
Patients included in this study were retrospectively re-
cruited from a digital CMR data base (including analyses
for diagnostic reports and image files), based on LVNC
diagnosis, for a period of 3.75 years. Entire set of im-
aging studies was reanalyzed by two experienced cardiol-
ogists and a radiologist. LVNC diagnosis included the
following CMR diagnostic criteria: non-compact-to-
compact layer >2.3:1, thinning of the compact myocar-
dium layer and trabeculations affecting >20% of the left
ventricle [3, 10, 12]. There were 2 (0.1%) cases with clin-
ically confirmed LVNC not fulfilling the criterion of
NC > 20% LV. In those cases, LVNC diagnosis was con-
firmed with the following clinical criteria: electrocardio-
graphic abnormalities, electrophysiology testing and in
one case, family history of cardiomyopathy and sudden
cardiac death. Cases with existing trabeculations whose
range did not fulfill the previously mentioned CMR cri-
teria in a clearly defined manner were included as a sub-
group of controls i.e. as the cases with suspected LVNC.
This sub-group of controls included patients with NC/C
ratio range of 1.8–2.2:1 and trabeculations affecting
>10% to <17% of LV. Control group of patients included
statistically comparable sample of individuals with: no
evidence of structural heart disease (healthy athletes,
those with arrhythmias and those referred to CMR for
ruling out of structural heart disease, prior to electro-
physiology studies, cardiac thrombosis or cardiomyop-
athy), hypertensive heart disease (HHD), hypertrophic
cardiomyopathy (HCM), dilative cardiomyopathy (DCM)
(considering exclusion of significant coronary artery dis-
ease), arrhythmogenic right ventricle cardiomyopathy
(ARVD) and subacute or late phase myocarditis (inclu-
sion of outpatients). Study did not include patients with
congenital heart disease, previous heart surgery, cardiac
tumors, significant pericardial effusion, primary valvular
disorder (aortic stenosis, mitral stenosis) and those with
coronary artery disease (having significant coronary ar-
tery disease (known stenoses >30%), positive adenosine
stress test for screening of coronary artery disease, or
ischemic type of late gadolinium enhancement).
Imaging studies were performed on 1.5 T Magnetom
Avanto, Siemens® (Erlangen, Germany, EU), using ECG
gating and breath-hold following two respiratory cycles,
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Body Matrix chest and spine coils. CMR protocol con-
sisted of setting localizers, Half-Fourier Acquisition
Single-shot Turbo spin Echo (HASTE) sequences, steady
state free precession (SSFP) of standard heart 2-, 4- and
3-chamber planes and 6 mm stack of short axial slices
(8–12 slices through ventricle), with adding of the right
ventricle and its outflow tract in case of any clinical
questions. In certain cases, that was followed by short
tau inversion recovery (STIR) or turbo spin echo (TSE)
T1 and T2 sequences dark blood, and fat saturation se-
quences, which was indicated prior to or during the
exam, on a case-to-case basis. Gadolinium contrast was
applied in a 0.2 mL/kg (0.1 mmol/kg) dose. An intraven-
ous bolus of Omniscan® [Gadodiamide, GE Healthcare,
Little Chalfont, UK, EU] or Dotarem® [gadoterate meglu-
mine, Guerbet, Roissy, France, EU] was used in the
exams, as well as late gadolinium enhancement (LGE)
sequences 20–30 min following the contrast application.
Postprocessing was performed on Siemens AG-
NUMARIS/4, Syngo MR B17® software package
(Erlangen, Germany, EU), whilst volumetric analyses
were done using Siemens AG- Syngo Console Argus®, by
a team made of two CMR high throughput cardiologists
(300–450 exams per year) and a radiologist. Standard re-
ports included a clinical questionnaire from the referring
cardiologist, medical history, interpretation of all planes,
sequences, tissue sequences, volumetrics, dedicated mea-
surements of myocardial thickness in trabecula and solid
part, indirect analysis of valvular function, late gadolin-
ium enhancement and conclusions arrived at based on
the exam. Final interpretation of the results was done in
accordance with the standardized myocardial segmenta-
tion, as recommended by professional associations. For
the purpose of this study, geometry included eccentricity
analyses in the dedicated region of the left ventricle, af-
fected by non-compaction, and the same i.e. comparable
region in the control group of patients, developed by the
principal author of the study (MB). Slices from the mid
to apical part (chosen from the 4th - 8th layer of short
axis stack of 6 mm slices, with typical range 8–12 per
patient) of the left ventricle short axis single slice, cre-
ated parallel to mitral valve by calculating the ratio of
the longest end diastolic diameter (EDD) divided by
the diameter of perpendicular line (solid to solid
myocardium), i.e. maximal/minimal end diastolic ratio
(MaxMinEDDR).
Population and studied groups were analyzed using
descriptive statistic and presented as means combined
with standard deviations or numbers with percentages.
Numeric variables were analyzed for differences by the
Mann-Whitney U test or Kruskal Wallis. Group data
analyses were calculated with Chi square or Kruskal
Wallis. Connections between the studied CMR parame-
ters and LVNC were described by Spearman Rho.
Bi-nominal regression analysis was used for the studied
CMR parameters and LGE existence. LVNC diagnostic
value of the late gadolinium enhancement and left ven-
tricular geometry was first calculated separately and then
in head to head settings using receiver operating charac-
teristic (ROC) curve analysis and NC/C plus NC > 20%
LV as previously standardized parameters. P value less
than 0.05 was considered significant. Statistical analyses
were done by an experienced statistician using IBM-
SPSS12® v 20 (IBM co, Chicago, IL, USA) MedCalc v.
12.2® for Windows (MedCalc software co, Belgium,
EU) and Statistica 10® for Windows (StatSoft inc,
Tulsa, OK, USA).
Results
Studied sample
The study included 255 cases referred for CMR a 3.75-
year period, covering 1975 exams. Control group of pa-
tients (n = 155; 60.8%) included cases with no structural
heart disease and those with non-ischemic cardiomyop-
athy other than LVNC. Patients with LVNC that fulfilled
all three CMR criteria (thinning, ratio and share, as pre-
viously explained) were included, making sample of one
hundred (39.2%) consecutive patients (5.1% prevalence
of total exams in the studied period) From those patients,
only 2 cases were confirmed by addition of clinical criteria
(not having >20% of trabeculations in the left ventricular
mass despite having NC/C > 2.3:1). Fifty-six cases (36.1%)
from the control group had clinically suspicious, but not
clearly defined LVNC. Detailed data on patients and stud-
ied groups are presented in Table 1.
Late gadolinium enhancement
LGE was found in 133 patients (52.2%) as follows: focal
mid-ventricular (MV) type was found in 35 (26.3%)
cases, linear MV in 83 (62.4%) and diffuse LGE in 15
(11.3%) cases. The most common type of LGE in LVNC
was linear MV, located in basal (n = 44) and basal/middle
sections (n = 8) of the left ventricle, whilst the patients
with no structural heart disease most commonly had no
LGE imbibition.
Correlations between LGE, geometry and LVNC diag-
nostic parameters for the studied sample of cases are
presented in Table 2.
Existence of LGE was found in cases with LVEF
≤49.2% using receiver operating characteristic curve ana-
lysis, with sensitivity of 50.8% (95%-CI:41.6–59.2, specifi-
city of 85.1% (95%-CI:77.5–90.9), +likelihood ratio (+LR)
of 3.4 (95%-CI:2.8–4.1), −LR of 0.6 (0.4–0.9), area under
curve (AUC) of 0.674 (95%-CI: 0.612–0.731, p < 0.001.
Using binomial regression analyzes, existence of LGE
was significantly connected with following studied param-
eters: LV-myocardial mass = 1.01 (95%-CI: 1.00–1.02), p =
0.048; LVEF = 0.97 (95%-CI: 0.95–0.98), p = 0.002 and
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Max-Min-EDDR 1.01 (95%-CI: 1.00–28.99), p = 0.045,
while the NC/C was not significant.
Differences between existence of LGE in patients with
LVNC and controls, with further sub-analyzes of type of
LGE are presented in Tables 3 and 4.
Geometry of the left ventricle
Max-Min-EDDR was 1.11 ± 0.09 (95%-CI: 1.01–1.26),
with significant difference between the patients with
LVNC and controls, 1.17 ± 0.09 vs. 1.06 ± 0.05, p < 0.001.
Similarly, Max-Min-EDDR of LVNC was significantly
different among all the sub-studied control groups (no
structural heart disease, 1.06 ± 0.04; hypertensive heart
disease, 1.07 ± 0.03; dilative cardiomyopathy 1.05 ± 0.04;
hypertrophic cardiomyopathy 1.08 ± 0.08; ARVD 1.07 ±
0.03 and myocarditis 1.05 ± 0.01), p < 0.001. In addition,
Max-Min-EDDR was significantly different between the
patients with no LGE imbibition and controls, 1.09 ±
0.08 vs. 1.12 ± 0.09, respectively, p = 0.039. Figure 1.
shows examples of geometric eccentricity in a patient
with LVNC and two other cardiomyopathies. Correla-
tions of Max-Min-EDDR and studied diagnostic parame-
ters is presented in Table 2.
Model of receiver operating characteristic curve ana-
lysis of Max-Min-EDDR for detection of systolic func-
tion impairment (defined with LVEF < 50%) was not
significant (AUC = 0.559; p = 0.121).
Diagnostic utility of CMR parameters for LVNC
Receiver operating characteristic (ROC) curve analysis
was used for diagnostic utility of the studied CMR pa-
rameters for establishing a LVNC diagnosis, in which
NC/C > 2.3:1 and NC > 20%LV were considered as the
gold standard.
Existing LGE had sensitivity of 52.5% (95%-CI:42.3–62.5),
specificity of 80.4% (95%-CI:73.2–86.5), +LR of 2.7 (95%-
CI:2.2–3.3), −LR of 0.6 (0.4–0.9), area under curve (AUC)
of 0.664 (95%-CI: 0.603–0.722); p < 0.001.
MaxMinEDDR being >1.10 (i.e. exactly 1.0975) had
sensitivity of 95.0% (95%-CI:88.7–98.4), specificity of
82.6% (95%-CI:75.7–88.2), +LR of 5.0 (95%-CI:5.0–5.9),
−LR of 0.1 (0.02–0.2), area under curve (AUC) of 0.917
(95%-CI: 0.876–0.948); p < 0.001.
Comparison of ROC curves for the studied diagnostic
parameters of LVNC was as follows: ROC-AUC (NC >
20%LV) = 0.985 (95%-CI: 0.961–0.996), ROC-AUC (NC/
C > 2.3:1) = 0.983 (95%-CI: 0.959–0.995), ROC-AUC
(MaxMinEDDR) = 0.909 (95%-CI: 0.866–0.941) and
ROC-AUC (linear-MV-LGE) = 0.664 (95%-CI:0.603–
0.722). There was also a significant difference between
ROC AUC for LGE and eccentricity, ΔAUC0.244 (95%-
CI:0.175–0.314), p < 0.001, as shown in Fig. 2.
Discussion
This study analyzed the existence and morphology of
LGE imbibitions, their connections with left ventricle
geometry, as well as their diagnostic utility for LVNC.
The “gold standard” for LVNC diagnosis using CMR
was defined by thinning of compact LV wall, NC/C >
2.3:1 and NC > 20%LV [11]. In these terms, our study
used substantially different methodology from several re-
cently published registry based studies that found higher
prevalence of trabeculations, but without serious prog-
nostic implications, most likely due to not having a pri-
mary objective of LVNC diagnostics per se, different
inclusion criteria and not assessing the existence of LGE
[20]. In addition, impairment of systolic function of the
left ventricle in our study was also more congruent with
previous reports [21].
Nearly a half of the studied patients with LVNC had
LGE imbibition, where the latter attained specificity and
Table 1 Differences between LVNC patients and controls
Controls LVNC Chi square
n = 155 n = 100
Male 95 (61.3%) 56 (56.0%) 0.401
Female 60 (38.7%) 44 (44.0%)
LVEF < 50% 37 (23.9%) 48 (48.0%) <0.001
OK 79 (51.0%) 0 (0.0%) <0.001
LVNC 0 (0.0%) 100 (100.0%)
DCM 27 (17.4%) 0 (0.0%)
HCM 33 (21.3%) 0 (0.0%)
ARVD 5 (3.2%) 0 (0.0%)
HHD 6 (3.9%) 0 (0.0%)
MCD 5 (3.2%) 0 (0.0%)
Controls LVNC Mann-Whitney
n = 155 n = 100
Age (years) 48.2 ± 15.4 45.5 ± 17.8 0.180
LA (cm2) 26.9 ± 8.6 25.6 ± 6.4 0.333
RA (cm2) 24.6 ± 7.6 23.1 ± 6.2 0.155
LVEDD (cm) 5.4 ± 1.0 5.7 ± 0.8 <0.001
IVS (cm) 1.2 ± 0.4 1.0 ± 0.2 0.001
EDV (mL) 160.3 ± 78.7 169.4 ± 61.3 0.036
ESV (mL) 79.4 ± 76.4 95.9 ± 69.1 <0.001
SV (mL) 84.4 ± 45.7 78.5 ± 25.6 0.244
LVEF (%) 55.3 ± 15.2 48.2 ± 12.7 <0.001
MM (gram) 122.2 ± 48.5 106.0 ± 36.3 0.006
LVNC Left ventricular non compaction, OK No structural heart disease, DCM
Dilative cardiomyopathy, HCM Hypertophic cardiomyopathy, ARVD Arrhythmogenic
right ventricle disease, HHD Hypertensive heart disease, MCD Myocarditis, LVEDD
(cm) Left ventricle end diastolic dimension in 4-chamber view, IVS (cm)
Interventricular septum thickness in 4-chamber view, LA (cm2) Left atrial
area in square centimeters in 4-chamber view, LVEF (%) Left ventricle ejection
fraction, EDV (mL) End diastolic volume, ESV (mL) End systolic volume, SV (mL)
Stroke volume, LVEF (%) Left ventricle ejection fraction, MM (gram) Myocardial
mass in end-diastole. Data shown as numbers with percentages or means with
standard deviations (SD). Significant values are outlined in bold
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sensitivity of 55–60% as a diagnostic parameter. Propor-
tion of patients with LGE in our study was in line with
previous reports on the left ventricle non-compaction
cardiomyopathy [22]. The most common pattern of LGE
in LVNC was linear midventricular, followed by none,
while only a small number of cases had diffuse imbibi-
tions [22]. Interestingly, linear midventricular LGE in pa-
tients with non-compaction was located in basal and
basal to middle sections of the left ventricle, whilst mid
apical regions with the most pronounced trabeculations
did not show clinically significant proportion of late im-
bibitions. Linear midventricular type of LGE was the
most common LGE type in patients with dilative cardio-
myopathy, focal type LGE was the most prevalent in
patients with hypertrophic cardiomyopathy, while the
patients with no structural heart disease predominantly
had no late imbibitions [23]. There were no significant
differences in LGE imbibition between the cases with
suspected LVNC and the remaining part of the control
group. The latter reveled the shortcomings of late gado-
linium imbibition as a diagnostic tool for differentiating
between the cases with increased trabeculations of the
left ventricle suspected of LVNC. However, it is worth-
while to note that the difference of LGE imbibition was
significant to cases with overt LVNC [24]. Existence of
LGE correlated only to a mild degree with the age of pa-
tients, and there was a strong inverse correlation with
systolic function of the left ventricle [25]. The former
seems to represent a time-dependent degenerative
process, and support the fact of overall underprivileged
prognostic course in patients with heart failure [26].
Critical cut-off point to the left ventricle ejection frac-
tion for existence of LGE was found to be set at ≤49.2%,
as an intermediate-grade sensitive and high-grade spe-
cific sign of systolic impairment [24]. Existence of LGE
imbibition in the left ventricle was connected with in-
creased end diastolic dimension, interventricular septum
thickness and enlarged atrial volumes, which could
imply further diagnostic-prognostic value of this param-
eter [27]. Regarding the LV-volumetrics, LGE was in
mild correlation with end diastolic volume, end systolic
volume and LV-myocardial mass. Changes in cardiomyo-
cytes, which made them susceptible for late gadolinium
imbibition, consequentially increased size of the left ven-
tricle and atria, while systolic function decreased, repre-
senting the point of down turning of the Frank-Starling
curve and value of LGE as the initial diagnostic land-
mark of the failing heart [28, 29].
Table 2 Correlations of LGE, geometry and other diagnostic parameters in the studied population sample (n = 255)
LVNC NC/C > 2.3:1 NC > 20%LV LGE LVEF < 50% C NC NC/C MIN EDD MAX EDD MaxMin EDDR
LVNC Rho CC NA 0.888 0.960 0.140 0.234 −0.668 0.560 0.795 −0.079 0.234 0.689
p <0.001 <0.001 0.025 <0.001 <0.001 <0.001 <0.001 0.206 <0.001 <0.001
MNC Rho CC 0.032 0.240 NA 0.066 0.114 −0.258 0.496 0.575 0.032 0.061 0.093
p 0.690 0.003 0.414 0.156 0.001 <0.001 <0.001 0.693 0.454 0.249
Age (years) Rho CC −0.094 −0.038 −0.095 0.137 0.110 0.118 0.061 −0.053 0.115 0.100 −0.087
p 0.136 0.544 0.132 0.029 0.080 0.060 0.333 0.395 0.066 0.110 0.168
LA (cm2) Rho CC −0.063 −0.087 −0.060 0.143 0.275 0.210 0.075 −0.085 0.522 0.506 −0.070
p 0.314 0.165 0.338 0.023 <0.001 0.001 0.233 0.176 <0.001 <0.001 0.268
EDV (mL) Rho CC 0.128 0.074 0.130 0.173 0.426 0.058 0.188 0.082 0.729 0.750 0.008
p 0.042 0.238 0.039 0.006 <0.001 0.359 0.003 0.192 <0.001 <0.001 0.905
ESV (mL) Rho CC 0.255 0.210 0.265 0.224 0.666 −0.041 0.294 0.218 0.685 0.726 0.059
p <0.001 0.001 <0.001 <0.001 <0.001 0.512 <0.001 <0.001 <0.001 <0.001 0.344
LVEDD (cm) Rho CC 0.209 0.182 0.226 0.206 0.520 0.006 0.318 0.196 0.656 0.689 0.043
p 0.001 0.004 <0.001 0.001 <0.001 0.930 <0.001 0.002 <0.001 <0.001 0.491
IVS (cm) Rho CC −0.196 −0.169 −0.220 0.262 0.057 0.377 −0.026 −0.251 0.202 0.130 −0.137
p 0.002 0.007 <0.001 <0.001 0.369 <0.001 0.676 <0.001 0.001 0.037 0.029
LVEF Rho CC −0.313 −0.309 −0.332 −0.301 −0.809 0.154 −0.330 −0.311 −0.507 −0.570 −0.117
p <0.001 <0.001 <0.001 <0.001 <0.001 0.014 <0.001 <0.001 <0.001 <0.001 0.062
MM (gram) Rho CC −0.157 −0.190 −0.168 0.202 0.253 0.395 0.025 −0.222 0.554 0.498 −0.144
p 0.012 0.002 0.007 0.001 <0.001 <0.001 0.687 <0.001 <0.001 <0.001 0.021
LVNC Left ventricular non compaction, NC/C > 2.3:1 NC to C ratio > 2.3:1 - non-compact to compact layers thickness ratio, LGE Late gadolinium enhancement,
NC> 20%LV Non-compact myocardium proportion > 20% of the left ventricle, EDD End diastolic dimension, Max maximal, Min minimal, MaxMinEDDR ratio of
maximal to minimal EDD, MNC Marginal non-compaction (clinical suspicions of LVNC), NA Not applicable, LVEDD (cm) Left ventricle end diastolic dimension in
4-chamber view, IVS (cm) Interventricular septum thickness in 4-chamber view, LA (cm2) Left atrial area in square centimeters in 4-chamber view, LVEF (%) Left
ventricle ejection fraction, EDV (mL) End diastolic volume, ESV (mL) End systolic volume, LVEF (%) Left ventricle ejection fraction, MM (gram) Myocardial mass
in end-diastole. Significant correlations presented in bold
Boban et al. BMC Cardiovascular Disorders  (2017) 17:286 Page 5 of 9
Cases with LVNC displayed structural rearrangements
in terms of geometric eccentricity of mid to apical short
axis sections, affected with non-compaction [30].
Eccentricity of the left ventricle was in significant and
powerful correlation with LVNC diagnosis and its diag-
nostic parameters. MaxMinEDDR did not correlate in
cases with clinical suspicion of LVNC or those with mul-
tiple cardiomyopathy elements, underscoring further
diagnostic value of geometric changes for LVNC. In
addition, correlation of Max-Min-EDDR with LVNC
diagnostic criteria attained powerful synergy, while its
constituents, taken individually had only mild or insig-
nificant correlations. Difference between maximal and
minimal end diastolic ratio of over 10% had 95% sensi-
tivity and 83% specificity for LVNC, making it a very
promising innovative diagnostic parameter. Patients with
LGE imbibitions also had significantly different eccentri-
city of the left ventricle, however in close numeric range
to controls (without LGE imbibition). Correlations of
LGE with the geometry of the left ventricle were signifi-
cant, though mild, leading to an assumption that LGE is
not in a straightforward relation with geometry, and that
it is more likely secondarily changed due to infrastruc-
tural rearrangements of the left ventricle which conse-
quently ended up as geometric eccentricity [31, 32]. In
head to head settings, MaxMinEDDR was shown to be a
superior diagnostic parameter than LGE, of similar diag-
nostic efficiency as the NC/C ratio or NC affecting more
than 20% of the left ventricle, with the last two consid-
ered as among the best currently available evidence for
diagnosing the LVNC [3, 12].
Geometry of the left ventricle was found to be con-
nected with functional prognostic parameters such as
systolic function or left atrial size [27]. The latter implies
that local infrastructural alternations in terms of non-
compaction eventually cause changes in the structure
and function beyond the left ventricle, which could serve
as a diagnostic landmark of the turning point of the fail-
ing heart. Systolic function of the left ventricle correlated
with maximal and minimal end diastolic diameters in
mid apical short axis slices, but not with MaxMinEDDR.
This was further confirmed as a clinically insignificant
diagnostic parameter of systolic dysfunction in ROC
analysis. Based on those results, assumptions could be
made that whilst systolic function of the left ventricle in
patients with LVNC tends to be decreased, the initial
disorder is probably hidden among the structural changes
of non-compact myocardium, and eminently ends up with
different grade of systolic dysfunction. There seems to be
sequential relation, where systolic dysfunction lags in
phase to infrastructural changes caused by non-compact
myocardium and changes of geometry.
One must point out that these are preliminary investi-
gations, focused on diagnostic utility of a single imaging
modality scrutinized according to guidelines-based diag-
nostic criteria that are not perfect. The study was
Table 3 Principal characteristics and differences in the studied sample, depending on the existence and type of late gadolinium
enhancement
No LGE LGE Chi
square
No LGE Focal MV Linear MV Diffuse Kruskal
Wallisn (%) n (%) n (%) n (%) n (%) n (%)
Male 64 (52.5%) 87 (65.4%) 0.031 64 (52.5%) 27 (77.1%) 49 (59.0%) 11 (73.3%) 0.038
Female 58 (47.5%) 46 (34.6%) 58 (47.5%) 8 (22.9%) 34 (41.0%) 4 (26.7%)
OK 67 (54.9%) 12 (9.0%) <0.001 67 (54.9%) 3 (8.6%) 7 (8.4%) 2 (13.3%) <0.001
LVNC 40 (32.8%) 60 (45.1%) 40 (32.8%) 4 (11.4%) 52 (62.7%) 4 (26.7%)
DCM 4 (3.3%) 23 (17.3%) 4 (3.3%) 3 (8.6%) 18 (21.7%) 2 (13.3%)
HCM 2 (1.6%) 31 (23.3%) 2 (1.6%) 22 (62.9%) 3 (3.6%) 6 (40.0%)
ARVD 4 (3.3%) 1 (0.8%) 4 (3.3%) 0 (0.0%) 1 (1.2%) 0 (0.0%)
HHD 4 (3.3%) 2 (1.5%) 4 (3.3%) 0 (0.0%) 2 (2.4%) 0 (0.0%)
MCD 1 (0.8%) 4 (3.0%) 1 (0.8%) 3 (8.6%) 0 (0.0%) 1 (6.7%)
LVEF < 50% 20 (16.4%) 65 (48.9%) <0.001 20 (16.4%) 13 (37.1%) 48 (57.8%) 4 (26.7%) <0.001
NC:C > 2.3:1 40 (32.8%) 67 (50.4%) 0.005 40 (32.8%) 6 (17.1%) 56 (67.5%) 5 (33.3%) <0.001
LVNC 40 (32.8%) 60 (45.1%) <0.001 40 (32.8%) 4 (11.4%) 52 (63.9%) 4 (26.7%) <0.001
MNC 27 (32.9%) 29 (39.7%) 0.410 27 (32.9%) 10 (32.3%) 14 (45.2%) 5 (45.5%) 0.560
MCE 26 (21.3%) 59 (44.4%) <0.001 26 (21.3%) 17 (48.6%) 33 (39.8%) 9 (60.0%) 0.001
NC > 20%LV 39 (32.0%) 59 (44.4%) 0.047 39 (32.0%) 3 (8.6%) 52 (62.7%) 4 (26.7%) <0.001
LGE late gadolinium enhancement, MV Midventricular, LVNC Left ventricular non compaction, OK No structural heart disease, DCM Dilative cardiomyopathy, HCM
Hypertophic cardiomyopathy, ARVD Arrhythmogenic right ventricle disease, HHD Hypertensive heart disease, MCD Myocarditis, LVEF (%) Left ventricle ejection
fraction, NC to C ratio Non-compact to compact layers thickness ratio, MNC Marginal non-compaction (clinical suspicion of LVNC), MCE Multiple cardiomyopathy
elements, NC > 20%LV Non-compact myocardium proportion > 20% of the left ventricle. Significant values outlined in bold
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performed in the only large-volume tertiary center spe-
cialized for CMR in our country, on a selected popula-
tion of cases with cardiovascular diseases and previous
cardiovascular diagnostic and/or therapeutic workup.
Retrospective study settings and selection of controls
also might conceal limitations. Prospective validation,
using multicentric settings, with inclusion of further
clinical parameters, such as patients’ comorbidities and
follow up of major adverse event rates is necessary to in-
crease reproducibility.
Conclusion
In conclusion, late gadolinium enhancement was found
to be frequently expressed in patients with LVCN. These
Fig. 1 Geometry of the left ventricle in various heart diseases Data labels: a Case of patient with left ventricular non-compaction and trabeculations
existing on 35.3% of the left ventricle, ejection fraction of 52% and confirmed non–compaction; short axis cine at end diastole (ED), marked white line
showing: 1) NC-layer thickness 2.22 cm, 2) C-layer thickness 0.57 cm, with NC/C = 3.9. 3) Maximal ED dimension 6.40 cm, 4) Minimal EDD 5.59 cm, giving
MaxMinEDDR = 1.14; (b) patient with hypertrophic cardiomyopathy: 1) 3.41 cm, 2) 2.40 cm, 3) 5.17 cm, 4) 5.16 cm i.e. Max-Min EDDR = 1.00; (c) patient with
dilative cardiomyopathy: 1) 7.20 cm, 2) 6.99 cm i.e. Max-Min EDDR = 1.03
Table 4 Characteristics of myocardial layers and left ventricle geometry in dependence of the existence of late gadolinium enhancement
No LGE LGE Mann-
Whitney
No LGE Focal MV Linear MV Diffuse Kruskal
WallisMean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Age (years) 44.9 ± 15.3 49.1 ± 17.2 0.029 44.9 ± 15.3 50.8 ± 16.8 49.0 ± 17.7 46.1 ± 16.3 <0.001
LVEDD (cm) 5.31 ± 0.66 5.73 ± 1.06 0.001 5.31 ± 0.66 5.39 ± 0.83 5.95 ± 1.09 5.33 ± 1.09 0.124
IVS (cm) 0.98 ± 0.17 1.19 ± 0.43 <0.001 0.98 ± 0.17 1.50 ± 0.55 1.04 ± 0.22 1.35 ± 0.57 <0.001
RV (cm) 3.71 ± 0.68 3.58 ± 0.79 0.230 3.71 ± 0.68 3.68 ± 0.69 3.57 ± 0.84 3.43 ± 0.70 0.424
LA (cm2) 24.88 ± 5.89 27.89 ± 8.95 0.023 24.88 ± 5.89 28.11 ± 7.21 28.06 ± 9.78 26.40 ± 8.10 0.105
RA (cm2) 22.82 ± 6.21 25.14 ± 7.68 0.016 22.82 ± 6.21 25.09 ± 6.57 25.23 ± 7.83 24.80 ± 9.57 0.064
EDV (mL) 149.4 ± 45.4 177.5 ± 88.5 0.006 149.4 ± 45.4 156.9 ± 50.3 190.4 ± 103.2 153.1 ± 47.8 0.014
ESV (mL) 66.4 ± 32.5 103.9 ± 94.2 <0.001 66.4 ± 32.5 79.4 ± 52.3 120.8 ± 110.0 67.3 ± 39.1 <0.001
SV (mL) 88.1 ± 49.6 76.6 ± 25.4 0.008 88.1 ± 49.6 77.0 ± 21.6 74.7 ± 26.6 85.8 ± 26.0 0.020
LVEF (%) 57.1 ± 8.8 48.2 ± 17.4 <0.001 57.1 ± 8.8 53.3 ± 17.5 44.4 ± 16.6 57.6 ± 16.0 <0.001
MM (gram) 105.8 ± 32.7 125.2 ± 51.9 0.001 105.8 ± 32.7 139.2 ± 38.0 119.5 ± 57.3 125.2 ± 44.1 <0.001
C- thickness (cm) 0.65 ± 0.20 0.67 ± 0.24 0.853 0.65 ± 0.20 0.84 ± 0.24 0.59 ± 0.21 0.73 ± 0.23 <0.001
NC- thickness (cm) 1.10 ± 0.46 1.18 ± 0.48 0.025 1.10 ± 0.46 0.96 ± 0.51 1.31 ± 0.42 1.01 ± 0.53 <0.001
NC to C ratio 1.99 ± 1.29 2.14 ± 1.20 0.127 1.99 ± 1.29 1.30 ± 0.85 2.58 ± 1.09 1.65 ± 1.27 <0.001
Minimal MA EDD (cm) 5.16 ± 0.66 5.43 ± 1.02 0.040 5.16 ± 0.66 5.19 ± 0.83 5.56 ± 1.14 5.25 ± 0.39 0.130
Maximal MA EDD (cm) 5.63 ± 0.75 6.04 ± 1.06 <0.001 5.63 ± 0.75 5.68 ± 0.69 6.24 ± 1.21 5.77 ± 0.48 <0.001
Max to Min EDD Ratio 1.09 ± 0.08 1.12 ± 0.09 0.039 1.09 ± 0.08 1.10 ± 0.11 1.13 ± 0.08 1.10 ± 0.11 0.005
LV trabeculations % 14.7 ± 11.2 17.4 ± 12.2 0.117 14.7 ± 11.2 8.2 ± 7.7 21.7 ± 11.7 13.4 ± 10.8 <0.001
LGE Late gadolinium enhancement, MV Midventricular, LVNC Left ventricular non compaction; LV-NC % - left ventricle non-compaction proportion in total mass of
the left ventricle, C-Compact (cm) Thickness of solid myocardium, NC-non-compact (cm) Thickness of trabeculated part i.e. non-compaction myocardium, LVEDD
(cm) Left ventricle end diastolic dimension in 4-chamber view, IVS (cm) Interventricular septum thickness in 4-chamber view, RV (cm) Right ventricle end diastolic
dimension in 4-chamber view, LA & RA (cm2) Left and right atrial area in square centimeters in 4-chamber view, LVEF (%) Left ventricle ejection fraction, EDV (mL)
End diastolic volume, ESV (mL) End systolic volume, SV (mL) Stroke volume, MM (gram) Myocardial mass in end-diastole, MA Mid to apical slices in 6-mm pile stack
of short axes, EDD End diastolic dimension, Max Maximal, Min Minimal. Data shown as mean with standard deviations (SD). Statistically significant values (p < 0.05)
presented in bold
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imbibitions were of insufficiently defined power to be
used as a specific diagnostic parameter, in the context of
LVNC. On the other hand, LGE was found to be a rela-
tively valuable diagnostic landmark of complex infra-
structural and functional changes within the failing
heart. It correlated only mildly with left ventricle geom-
etry in dedicated regions, where the latter was found to
be a very promising novel LVNC diagnostic parameter.
Geometric eccentricity associated with LVNC had a fine
grade of diagnostic utility to tell apart the cases with
non-ischemic cardiomyopathies from those with struc-
turally normal heart. Segmental eccentricity was also in
correlation with infrastructural and functional changes
that even stretched beyond mid-apical regions, i.e. to the
whole left ventricle and both atria. Changes of left ven-
tricle geometry in addition to tissue characterization by
late gadolinium imbibition seem to have potential for
further contribution to the diagnostic imaging of the
failing heart.
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